Pavnit Kukreja
机构：AbbVie (United States)
发表论文 63 篇 · 总被引 660 次 · h-index 13
代表论文
- Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance (2024 · Clinical Parkinsonism & Related Disorders · 被引 41)
- Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results (2023 · Journal of Parkinson s Disease · 被引 40)
- Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa (2024 · Movement Disorders Clinical Practice · 被引 19)
- Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort (2023 · Parkinsonism & Related Disorders · 被引 15)
- Association of patient characteristics, social drivers of health, and geographic location on access to device-aided therapies among medicare beneficiaries with advanced Parkinson's disease (2025 · Parkinsonism & Related Disorders · 被引 11)
- Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease (2025 · Movement Disorders Clinical Practice · 被引 10)